Australian Healthcare Services Stock News

Wondering if Austal at $6.23 is still a smart buy after its big run, or if you would just be chasing momentum? Let us unpack what the current price really implies about its value. The stock has slipped slightly in the short term, down 4.4% over the last week and 7.2% over the last month, but that comes after a huge rebound with shares up 101.0% year to date and 122.5% over the past year. Much of this surge has been driven by renewed optimism around Austal's defence shipbuilding contracts and...

With a price-to-sales (or "P/S") ratio of 0.3x Sequoia Financial Group Limited ( ASX:SEQ ) may be sending very bullish...

Key Insights Significant control over Aurelia Metals by individual investors implies that the general public has more...

Key Insights Significant control over Asara Resources by retail investors implies that the general public has more...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Emmerson Resources...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

LaserBond Limited ( ASX:LBL ) shareholders have had their patience rewarded with a 26% share price jump in the last...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Buying shares in the best businesses can build meaningful wealth for you and your family. While the best companies are...

Castile Resources Limited ( ASX:CST ) shareholders (or potential shareholders) will be happy to see that insider Peter...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Brightstar Resources (ASX:BTR) has caught traders attention after fresh drilling at its Sandstone Hub delivered high grade gold hits at the Bull Oak and Havilah deposits, alongside progress on its updated Pre Feasibility Study. See our latest analysis for Brightstar Resources. The market seems to be catching on to that story, with a 1 day share price return of 13.68% and a stronger 7 day share price return of 20.00%. This has helped turn a relatively modest year to date share price gain and a...

GPT Group has recently launched “Offline” at Queensland’s largest shopping centre, Pacific Fair, turning previously underused space into a rotating, short‑term physical hub for popular online-only brands. This concept highlights GPT’s attempt to blend e-commerce influence with in-person retail, potentially boosting centre vibrancy, tenant appeal and customer engagement. We’ll now explore how repurposing underutilised space for online brands’ pop-up stores may influence GPT Group’s broader...

Earlier this week, Goldman Sachs initiated coverage on Cleanaway Waste Management with a Buy rating, emphasizing the company’s strong position in Australia’s waste ecosystem and its national operating scale. The broker’s focus on policy-driven recycling demand, efficiency improvements, new infrastructure, and recent acquisitions highlights how multiple growth levers could influence Cleanaway’s future earnings profile. We’ll now examine how Goldman Sachs’ focus on policy-led recycling demand...

Fortescue (ASX:FMG) is back on traders’ radars after punching up to a new 52 week high, helped by firmer iron ore prices and growing interest in its hydrogen based steelmaking partnership with Taiyuan. See our latest analysis for Fortescue. That move to A$22.98 caps a strong run, with a roughly 15% one month share price return and around 25% one year total shareholder return. This suggests momentum is building as investors re-rate Fortescue’s green iron and decarbonisation push. If...

On 2 December 2025, South32 Limited appointed Geoff Healy as an independent Non-Executive Director, with shareholders to vote on his election at the 2026 AGM. Healy’s blend of senior legal, external affairs, and climate-focused advisory experience from BHP and BCG may influence South32’s governance and sustainability priorities. Now we’ll explore how Healy’s boardroom influence could shape South32’s investment narrative, particularly its climate strategy and project execution. Rare earth...

Earlier this week, AMP agreed in principle to pay A$29 million to settle a long-running class action over adviser-recommended in-house life insurance products, with no admission of liability and final approval still subject to the courts. This resolution marks another step in AMP’s effort to close legacy conduct issues following a recent A$120 million superannuation fee settlement, potentially reducing litigation overhang on its reshaped wealth, banking, and retirement business. We’ll now...

Evolution Mining (ASX:EVN) has just deepened its push into battery metals, lifting its stake to roughly 26% in the Nevada North Lithium joint venture and funding the next exploration phase in Nevada. See our latest analysis for Evolution Mining. The stronger position in Nevada North Lithium seems to be feeding into sentiment, with Evolution’s 90 day share price return of 28.89% and one year total shareholder return of 159.26% suggesting momentum is still building from a much longer...

Meteoric Resources NL reported that the vote on the Preliminary Environmental Licence for its Caldeira Rare Earth Project in Minas Gerais, Brazil, was postponed after the state environmental authority requested more time to address questions from the Federal Public Prosecutor's Office. The company highlighted that a comprehensive 3,000-page Environmental Impact Assessment and a favourable technical report from the state regulator underpin its confidence that existing submissions already...

Earlier this month, Neuren Pharmaceuticals disclosed that the FDA’s pre-IND meeting for its NNZ-2591 program was pushed back by one month to late January 2026, citing an administrative delay that could modestly affect the development timeline for hypoxic ischemic encephalopathy and other rare neurological indications. This seemingly short postponement is important because NNZ-2591 is Neuren’s second key asset, already granted orphan drug designation in the US and EU, and any shift in its...

Regis Healthcare has sold its Ayr and Home Hill aged care homes in Far North Queensland to Ozcare, crystallising an expected one-off pre-tax gain of about A$25 million in FY26 and reducing its regional bed count by 156. This divestment marks a shift toward a leaner, city-focused portfolio that analysts suggest could support more efficient operations and improved margins. Next, we’ll examine how Regis’ move away from regional beds toward higher-efficiency metropolitan facilities could...

Deep Yellow (ASX:DYL) has been busy on the capital management front, rolling out new performance rights, issuing shares to employees, and seeing directors lift their personal stakes, all squarely aimed at alignment rather than headline grabbing. See our latest analysis for Deep Yellow. Those insider friendly moves are landing against a strong backdrop, with the latest A$1.935 share price sitting on a punchy year to date share price return. The three and five year total shareholder returns...

Aeris Resources (ASX:AIS) has just announced the immediate resignation of long serving Non Executive Director Robert Millner AO for personal reasons, prompting fresh questions about board composition and future strategic direction. See our latest analysis for Aeris Resources. The timing of Millner’s departure comes as investors have already been re-rating Aeris, with the share price at A$0.54 and a 30 day share price return of 21.35 percent. This has fed into a powerful year to date share...